Quality accreditation

Informed Genomics Limited (IGL), trading as Nonacus Clinical Services (NCS), is committed to the provision of a high quality, efficient, accurate and responsive analytical, diagnostic and advisory service. NCS will evolve, develop, and continue to offer a professional service which meets the needs and requirements of all its users.

It is the policy of NCS to maintain and manage an integrated and effective Management System (MS). The MS shall integrate the company’s procedures, processes and resources and will be monitored and reviewed on a continual basis whilst ensuring continual quality improvement is adhered to in accordance with the requirements of ISO 15189:2022 (UKAS reference number: 22262).

NCS is committed to user satisfaction and the main goals of the company are:

• To comply with the ISO 15189:2022 standard whilst committing to good professional practice and conduct.
• To establish, monitor and review the company measurable quality objectives.
• To promote quality throughout the business and ensure all personnel are familiar with the quality policy, the MS and all associated procedures.
• To ensure personnel are familiar with the roles and responsibilities of each department and individual within the company MS.
• To operate a healthy and safe working environment for staff and visitors, complying with statutory environmental, health and safety regulations.
• To identify and work with suppliers and partners who maintain a high level of quality assurance.
• To recruit, train, retain and develop all staff of all levels to achieve the standards required to provide a full and effective service to users.
• To procure and effectively maintain equipment and other resources needed for the provision of the service.
• To correctly handle specimens to ensure the correct performance of laboratory examinations.
• To report results of examinations in a timely, confidential, accurate and clinically useful manner.
• To ensure new and existing examination procedures are fit for purpose.
• To perform regular audits of our internal processes.
• To undertake all company activities impartially as NCS is committed to unbiased practices.
• To use internal and external quality assessment and participation in appropriate regional and national external quality assessment schemes (e.g., GENQA) as this reinforces impartiality and competence.
• To have a greater focus on clinical risk and impact on end user care.